All In MedTech

Device Trial Radar · NCT07436156

SUMMIT RISE Study of Acute Ischemic Stroke Patients

SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.

Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Feb 12, 2026

Primary completion

May 31, 2029

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Route 92 Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Conditions

  • Acute Ischemic Stroke

Interventions

  • Route 92 Medical Reperfusion SystemsDevice

    Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Periprocedural eTICI measurement of revascularizationTime frame: Periprocedural

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Route 92 Medical, Inc.

    West Jordan, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.